Vitaspring Biomedical VSBC
OTC VSBC
$0.01 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Vitaspring Biomedical Co. Ltd. (VSBC) EBITDA Margin (2017 - 2022)

Updated

Vitaspring Biomedical's EBITDA Margin came in at 23.28% for fiscal Q1 2023 (quarter ended Apr 30, 2022), down 17.51 percentage points from the prior quarter.

Analysis

Vitaspring Biomedical Co. Ltd. (VSBC) EBITDA Margin (2017 - 2022) Analysis & Trends

For FY2022 (ended Jan 31, 2022), Vitaspring Biomedical's EBITDA Margin was 20.22%, up 191.61 percentage points from FY2021.

  • EBITDA Margin carries a four-year change of +57.18 percentage points (FY2018 to FY2022).
  • Going back by fiscal year, EBITDA Margin was -171.39% in FY2021 (-220.06 pp), 48.67% in FY2020 (+176.41 pp), -127.74% in FY2019 (-90.78 pp) and -36.96% in FY2018.
  • The fiscal Q1 2023 figure represents the lowest quarterly EBITDA Margin since fiscal Q4 2021.
  • The fastest year-over-year change in EBITDA Margin over five years came in fiscal Q4 2019 (a gain of 703.64 percentage points), and the weakest in fiscal Q3 2019 (a drop of 16750.41 percentage points).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2022 23.28%
Jan 31, 2022 40.79%
Oct 31, 2021 70.61%
Jan 31, 2021 -139.29%
Jan 31, 2020 -138.76%
Apr 30, 2019 -116.40%
Jan 31, 2019 2,621.88%
Oct 31, 2018 -16,753.33%
Jul 31, 2018 -592.80%
Apr 30, 2018 40.89%
Jan 31, 2018 1,918.24%
Oct 31, 2017 -2.92%
Jul 31, 2017 -21.12%
Apr 30, 2017 186.94%
API Access

Vitaspring Biomedical Co. Ltd. EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VSBC&period=max&api_key=YOUR_API_KEY